0.97
price down icon2.02%   -0.02
after-market Handel nachbörslich: .95 -0.02 -2.06%
loading
Schlusskurs vom Vortag:
$0.99
Offen:
$0.99
24-Stunden-Volumen:
151.96K
Relative Volume:
0.67
Marktkapitalisierung:
$61.72M
Einnahmen:
$33.79M
Nettoeinkommen (Verlust:
$-18.67M
KGV:
-2.708
EPS:
-0.3582
Netto-Cashflow:
$-19.17M
1W Leistung:
-3.00%
1M Leistung:
-3.00%
6M Leistung:
-18.49%
1J Leistung:
+1.57%
1-Tages-Spanne:
Value
$0.945
$1.05
1-Wochen-Bereich:
Value
$0.945
$1.05
52-Wochen-Spanne:
Value
$0.70
$1.61

Cytosorbents Corp Stock (CTSO) Company Profile

Name
Firmenname
Cytosorbents Corp
Name
Telefon
973-329-8885
Name
Adresse
305 COLLEGE ROAD EAST, PRINCETON, NJ
Name
Mitarbeiter
186
Name
Twitter
@CytoSorbents
Name
Nächster Verdiensttermin
2025-03-31
Name
Neueste SEC-Einreichungen
Name
CTSO's Discussions on Twitter

Vergleichen Sie CTSO mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Devices icon
CTSO
Cytosorbents Corp
0.97 61.72M 33.79M -18.67M -19.17M -0.3582
Medical Devices icon
ABT
Abbott Laboratories
124.44 224.21B 41.95B 13.40B 6.35B 7.65
Medical Devices icon
SYK
Stryker Corp
345.80 142.48B 22.60B 2.99B 3.49B 7.76
Medical Devices icon
BSX
Boston Scientific Corp
89.70 138.89B 16.75B 1.85B 2.37B 1.25
Medical Devices icon
MDT
Medtronic Plc
82.88 112.70B 33.20B 4.26B 5.47B 3.29
Medical Devices icon
EW
Edwards Lifesciences Corp
69.36 41.63B 5.72B 4.17B 259.90M 6.97

Cytosorbents Corp Stock (CTSO) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-09-07 Eingeleitet B. Riley Securities Buy
2021-10-14 Fortgesetzt B. Riley Securities Buy
2020-09-17 Eingeleitet Jefferies Buy
2020-09-01 Eingeleitet SVB Leerink Outperform
2017-08-08 Bestätigt Maxim Group Buy
2016-10-26 Eingeleitet Aegis Capital Buy
2016-05-24 Eingeleitet Maxim Group Buy
2015-10-29 Hochstufung WBB Securities Speculative Buy → Buy
2015-05-12 Bestätigt MLV & Co Buy
2015-04-01 Bestätigt MLV & Co Buy
2015-03-05 Eingeleitet MLV & Co Buy
2015-02-25 Eingeleitet WBB Securities Speculative Buy
2015-01-27 Bestätigt H.C. Wainwright Buy
Alle ansehen

Cytosorbents Corp Aktie (CTSO) Neueste Nachrichten

pulisher
07:15 AM

CytoSorbents extends Series B Warrants expiration to June 10 - Investing.com

07:15 AM
pulisher
07:11 AM

Cytosorbents CorpExtends Expiration Date Of Series B Right Warrants To June 10, 2025SEC Filing - MarketScreener

07:11 AM
pulisher
07:00 AM

CytoSorbents Extends Expiration Date of Outstanding Series B Right Warrants - PR Newswire

07:00 AM
pulisher
Apr 03, 2025

Cytosorbents (NASDAQ:CTSO) Coverage Initiated at StockNews.com - Defense World

Apr 03, 2025
pulisher
Apr 02, 2025

Cytosorbents (NASDAQ:CTSO) Given Buy Rating at D. Boral Capital - Defense World

Apr 02, 2025
pulisher
Apr 01, 2025

Cytosorbents Corp Reports Strong Growth Amid Challenges - TipRanks

Apr 01, 2025
pulisher
Apr 01, 2025

CytoSorbents Corp Q4 2024 Earnings: EPS Misses at -$0.06, Revenue Falls Short at $9.2 Million - GuruFocus

Apr 01, 2025
pulisher
Apr 01, 2025

The Analyst Verdict: CytoSorbents In The Eyes Of 4 Experts - Benzinga

Apr 01, 2025
pulisher
Apr 01, 2025

Cytosorbents Corporation (NASDAQ:CTSO) Q4 2024 Earnings Call Transcript - Insider Monkey

Apr 01, 2025
pulisher
Apr 01, 2025

CytoSorbents Corp (CTSO) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance

Apr 01, 2025
pulisher
Apr 01, 2025

CytoSorbents Corp (CTSO) Q4 2024 Earnings Call Highlights: Stron - GuruFocus

Apr 01, 2025
pulisher
Mar 31, 2025

CytoSorbents Corporation Reports Strong 2024 Performance - TipRanks

Mar 31, 2025
pulisher
Mar 31, 2025

CytoSorbents: Q4 Earnings Snapshot - MySA

Mar 31, 2025
pulisher
Mar 31, 2025

Earnings call transcript: Cytosorbents Crp Q4 2024 beats EPS forecast By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 31, 2025

Cytosorbents Corp reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 31, 2025
pulisher
Mar 31, 2025

Cytosorbents Corp SEC 10-K Report - TradingView

Mar 31, 2025
pulisher
Mar 31, 2025

CytoSorbents Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights - TradingView

Mar 31, 2025
pulisher
Mar 31, 2025

CYTOSORBENTS Earnings Results: $CTSO Reports Quarterly Earnings - Nasdaq

Mar 31, 2025
pulisher
Mar 31, 2025

CytoSorbents Corp (CTSO) Reports Q4 Revenue Between $9.0M and $9 - GuruFocus

Mar 31, 2025
pulisher
Mar 28, 2025

Cytosorbents (CTSO) Expected to Post Improved Earnings and Reven - GuruFocus

Mar 28, 2025
pulisher
Mar 28, 2025

Insights into CytoSorbents's Upcoming Earnings - Benzinga

Mar 28, 2025
pulisher
Mar 26, 2025

Cytosorbents (NASDAQ:CTSO) Now Covered by StockNews.com - Defense World

Mar 26, 2025
pulisher
Mar 24, 2025

CytoSorbents Corp (CTSO) Q4 2024 Earnings Report Preview: What t - GuruFocus.com

Mar 24, 2025
pulisher
Mar 24, 2025

Cytosorbents (CTSO) Expected to Announce Quarterly Earnings on Monday - Defense World

Mar 24, 2025
pulisher
Mar 21, 2025

CytoSorbents Reschedules Earnings Release to March 31, 2025 to Allow Additional Time to Complete Annual Audit - Longview News-Journal

Mar 21, 2025
pulisher
Mar 21, 2025

CytoSorbents Q4 Revenue Jumps 25% Despite Earnings DelayKey Metrics Released - StockTitan

Mar 21, 2025
pulisher
Mar 18, 2025

Cytosorbents (NASDAQ:CTSO) Share Price Passes Above Two Hundred Day Moving Average – Here’s Why - Defense World

Mar 18, 2025
pulisher
Mar 10, 2025

CytoSorbents Stock Price, Quotes and Forecasts | NASDAQ:CTSO - Benzinga

Mar 10, 2025
pulisher
Mar 10, 2025

Cytosorbents (NASDAQ:CTSO) shareholders have endured a 78% loss from investing in the stock five years ago - Yahoo Finance

Mar 10, 2025
pulisher
Mar 10, 2025

StockNews.com Initiates Coverage on Cytosorbents (NASDAQ:CTSO) - Defense World

Mar 10, 2025
pulisher
Mar 06, 2025

CytoSorbents Corp. to Host Earnings Call - ACCESS Newswire

Mar 06, 2025
pulisher
Mar 05, 2025

CytoSorbents Corp (CTSO) Q4 2024 Earnings Report Preview: What T - GuruFocus.com

Mar 05, 2025
pulisher
Mar 05, 2025

CytoSorbents Corp (CTSO) Q4 2024 Earnings Report Preview: What To Expect - Yahoo Finance

Mar 05, 2025
pulisher
Mar 04, 2025

Cytosorbents Corp Reaffirms Preliminary Financial Expectations For Q4 And FY 2024 -March 04, 2025 at 04:52 pm EST - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

CytoSorbents delays earnings call after VP’s passing - Investing.com India

Mar 04, 2025
pulisher
Mar 04, 2025

CytoSorbents Corporation Postpones Earnings Call Following Loss of Vice President and Corporate Controller - Nasdaq

Mar 04, 2025
pulisher
Mar 04, 2025

CytoSorbents delays earnings call after VP’s passing By Investing.com - Investing.com Canada

Mar 04, 2025
pulisher
Mar 04, 2025

CytoSorbents Delays Earnings But Confirms 25% Growth: What's Behind The Postponement? - StockTitan

Mar 04, 2025
pulisher
Mar 03, 2025

StockNews.com Begins Coverage on Cytosorbents (NASDAQ:CTSO) - The AM Reporter

Mar 03, 2025
pulisher
Mar 02, 2025

Cytosorbents (NASDAQ:CTSO) Now Covered by Analysts at StockNews.com - Defense World

Mar 02, 2025
pulisher
Feb 27, 2025

Cytosorbents (NASDAQ:CTSO) Earns “Buy” Rating from D. Boral Capital - Defense World

Feb 27, 2025
pulisher
Feb 27, 2025

Cytosorbents (CTSO) to Release Quarterly Earnings on Thursday - Defense World

Feb 27, 2025
pulisher
Feb 26, 2025

When Will CytoSorbents Release Q4 2024 Results? Key Date for Investors - StockTitan

Feb 26, 2025
pulisher
Feb 26, 2025

CytoSorbents to Report Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights - Yahoo Finance

Feb 26, 2025
pulisher
Feb 25, 2025

CytoSorbents secures $1.6 million from warrant exercises - Investing.com

Feb 25, 2025
pulisher
Feb 25, 2025

CytoSorbents Secures $1.6M Capital InjectionWill This Fuel Their FDA Application Success? - StockTitan

Feb 25, 2025
pulisher
Feb 19, 2025

Cytosorbents Co. (NASDAQ:CTSO) Sees Significant Increase in Short Interest - Defense World

Feb 19, 2025
pulisher
Feb 18, 2025

B. Riley Securities initates Cytosorbents Corp (CTSO) rating to a Buy - Knox Daily

Feb 18, 2025
pulisher
Feb 15, 2025

CTSO stock touches 52-week high at $1.6 amid robust annual growth - MSN

Feb 15, 2025
pulisher
Feb 14, 2025

Cytosorbents (NASDAQ:CTSO) Stock Passes Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat

Feb 14, 2025
pulisher
Feb 14, 2025

Cytosorbents (NASDAQ:CTSO) Stock Passes Above Two Hundred Day Moving Average – Should You Sell? - Defense World

Feb 14, 2025

Finanzdaten der Cytosorbents Corp-Aktie (CTSO)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
medical_devices STE
$212.61
price down icon 3.97%
medical_devices PHG
$22.08
price down icon 7.46%
medical_devices ZBH
$107.34
price down icon 4.72%
$59.83
price down icon 3.19%
$60.51
price down icon 15.96%
medical_devices EW
$69.36
price down icon 4.96%
Kapitalisierung:     |  Volumen (24h):